Hangzhou Tigermed Consulting Co Ltd operates in the Medical laboratories sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Hangzhou Tigermed Consulting Co Ltd with three other
pharmaceutical manufacturers in Asia:
Medical & Biological Laboratories Company Limited
sales of 7.61 billion Japanese Yen [US$66.37 million]
of which 99%
was Reagent business),
Dr. Lal PathLabs Ltd
(6.60 billion Indian Rupees [US$96.70 million]
of which 100%
was Healthcare), and
Prodia Widyahusada Tbk PT
based in Indonesia
(1.20 trillion Indonesian Rupiahs [US$89.71 million]
Hangzhou Tigermed Consulting Co Ltd reported sales of 956.97 million Chinese Renmimbi (US$139.93 million)
December of 2015.
increase of 53.2%
versus 2014, when the company's sales were 624.55 million Chinese Renmimbi.
Sales at Hangzhou Tigermed Consulting Co Ltd have increased during each of the previous five years
(and since 2010, sales have increased a total of 696%).
Sales of Other saw an increase
that was more than double the company's growth rate: sales were up
223.3% in 2015, from
13.88 million Chinese Renmimbi to 44.87 million Chinese Renmimbi.